Tricida, Inc. — Form D
Tricida, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2017-11-15. The offering totals $57.6M, of which $57.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2017-11-15
- Form: D
- Accession: 0001595585-17-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $57.6M
- Amount sold: $57.6M
- Investors: 13
- Date of first sale: 2017-11-07
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-298743
Issuer
- Name: Tricida, Inc.
- CIK: 0001595585
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2013
- Address: 7000 SHORELINE COURT, SUITE 201, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 415-429-7800
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Robert Alpern | Director | South San Francisco, CA |
| David Bonita | Director | New York, NY |
| Sandra Coufal | Director | Los Angeles, CA |
| David Hirsch | Director | San Diego, CA |
| Gerrit Klaerner | Director | Santa Clara, CA |
| Klaus Veitinger | Director | Chanhassen, MN |
| Jerry Buysse | Executive Officer | South San Francisco, CA |
| Edward Hejlek | Executive Officer | South San Francisco, CA |
| Gerrit Klaerner | Executive Officer | Santa Clara, CA |
| Claire Lockey | Executive Officer | South San Francisco, CA |
| Geoffrey Parker | Executive Officer | San Francisco, CA |
| Wilhelm Stahl | Executive Officer | South San Francisco, CA |
| Melissa Miksch | Executive Officer | South San Francisco, CA |
Other filings by this issuer (3)
More